Anxiety Disorder of Childhood

3

Review clinical trials related to Anxiety Disorder of Childhood. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Implementation of a Just-In-Time Adaptive Intervention for Adolescent Anxiety

The goal of this clinical trial is to evaluate a smartphone based just-in-time adaptive intervention (JITAI) tool to deliver somatic behavioral recommendations for anxiety management among youth. The main questions it aims to answer are: * Is the JITAI tool acceptable among the adolescent study population? * Is the JITAI tool feasible to deliver to the adolescent study population? * Does the study support preliminary efficacy of the JITAI tool among the adolescent study population? The tool will be pilot-tested among a sample of 50 rural adolescents experiencing elevated anxiety levels who will be randomly assigned to the JITAI tool or a waitlist control, for a treatment period of 3 months. Participants will be asked to: * Use the smartphone based JITAI tool which will deliver somatic behavioral recommendations intended to manage anxiety levels for a treatment period of 3 months * Respond to the tool's prompts on a daily basis and follow the delivered behavioral recommendations * Complete anxiety and interoception assessments at study start, study end (3 months), and one-month follow-up * Complete usability and user experience instruments at study end (3 months)

Participants needed: 50
Trial details
Age: 13-17Biological sex: AllType: InterventionalSponsor: Trustees of Dartmouth CollegeUpdated: Apr 2, 2026
Eligibility criteria

Adolescent (age 13-17 years old) [+4]

Under 13 years old [+4]

Status: Recruiting

VR Homework Exercises for Selective Mutism Treatment

Selective mustism (SM) is an anxiety disorder that manifests in childhood. Children with Children with SM do not speak in certain social situations where this is expected of them. For example, a child may talk at home, but is afraid to speak at school. The goal of this clinical trial is to determine the efficacy of behavioral therapy for children with selective mutism (SM) combined with virtual reality (VR) homework exercises. Virtual Reality Exposure is an effective treatment for adults with anxiety disorders. The main questions to answer are: * Is behavioral therapy combined with VR homework exercises effective in the treatment of SM? * Which familial factors contribute to a positive treatment outcome and homework adherence? A single-case experimental design (SCED) will be used to evaluate the efficacy of the treatment. The child's speaking behavior at baseline will be compared to the child's speaking behavior in the different phases of the intervention. Participants will: * Follow individual therapy sessions at school. * Practice with the VR homework exercises at least once a week. * Parents and teachers will evaluate the child's speaking behavior.

Participants needed: 15
Trial details
Age: 4-13Biological sex: AllType: InterventionalSponsor: Luuk StapersmaUpdated: Mar 18, 2025Locations: 1
Eligibility criteria

The child meets the DSM-5 criteria for SM (as a primary classification). [+4]

No participating parents. [+6]

Status: Recruiting

Efficacy Trial of the CALM Intervention

Excessive anxiety among elementary students is highly prevalent and associated with impairment in academic, social, and behavioral functioning. The primary aim of this project is to evaluate the initial efficacy of a brief nurse-delivered intervention (CALM: Child Anxiety Learning Modules), relative to a credible comparison (CALM-R, relaxation skills only) and a waitlist control for reducing anxiety symptoms and improving education outcomes at post intervention and at a 1-year follow-up. In addition, the research team will assess the cost effectiveness of CALM versus CALM-R and the waitlist control and examine potential predictors, moderators, and mediators of CALM's impact on child outcomes based on the proposed theory of change.

Participants needed: 218
Trial details
Age: 5-12Biological sex: AllType: InterventionalSponsor: UConn HealthUpdated: Dec 9, 2024Locations: 2
Eligibility criteria

Be between the ages of 5-12 [+3]

Children who do not meet the inclusion criteria [+3]